Home | Welcome to Contract Pharma   
Last Updated Wednesday, October 1 2014
Print RSS Feed

OctoPlus, Sanofi Sign Master Service Agreement



Published January 10, 2013
Related Searches: Development Formulation Development formulation
OctoPlus N.V. has signed a Master Service Agreement with Sanofi. This agreement follows an ongoing collaboration for the development of a number of formulations. Further details on the compound and activities are not disclosed.
 
Mr. Jan Egberts, chief executive officer of OctoPlus, said, "We are proud of the confidence Sanofi has shown in our organization by signing this agreement. It reflects the success of our scientists and engineers who continuously develop new formulations and formulation processes, thereby strongly adding to the value of our clients' products."


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On